BRCA in breast cancer: ESMO Clinical Practice Guidelines

Judith Balmañà(Vall d'Hebron Hospital Universitari), M. Castiglione(University of Geneva), Orland Dı́ez(Vall d'Hebron Hospital Universitari), Isabel T. Rubio(Clinica Universidad de Navarra)

Annals of Oncology

May 1, 2010

10.1093/annonc/mdq161

Cited by 206

Related Papers

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2019|2.2k

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

|New England Journal of Medicine|2016|2k

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation

|Journal of Clinical Oncology|2014|1.7k

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

|Annals of Oncology|2012|1.5k

PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition

|Cancer Discovery|2012|622